China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.240 HKD | -3.85% |
|
-5.57% | -4.72% |
| 01/06 | China Resources Pharma Unit Gets China Acceptance for 5 Billion Yuan Bond Issue; Shares Climb 3% | MT |
| 28/04 | China Resources Pharmaceutical Unit Sells 1.4 Billion Yuan Bonds | MT |
| Market Cap | 2.66TCr 339.64Cr 297.39Cr 274.54Cr 256.37Cr 482.6Cr 32TCr 493.6Cr 3.3TCr 1.28TCr 16TCr 1.28TCr 1.25TCr 55TCr | P/E 2026 * |
5.63x | P/E 2027 * | 5.26x |
|---|---|---|---|---|---|
| Enterprise Value | 8TCr 1.02TCr 893.02Cr 824.41Cr 769.85Cr 1.45TCr 96TCr 1.48TCr 9.92TCr 3.83TCr 48TCr 3.83TCr 3.75TCr 1,65200Cr | EV / Sales 2026 * |
0.25x | EV / Sales 2027 * | 0.22x |
| Free-Float |
28.62% | Yield 2026 * |
4.66% | Yield 2027 * | 5.08% |
| 1 day | -3.85% | ||
| 1 week | -5.57% | ||
| Current month | -9.21% | ||
| 1 month | -11.11% | ||
| 3 months | -25.61% | ||
| 6 months | -5.36% | ||
| Current year | -4.72% |
| 1 week | 4.22 |  | 4.53 |
| 1 month | 4.22 | | 4.98 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Fang Jiao
BRD | Director/Board Member | 49 | 14/01/2022 |
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Chuan Guo
BRD | Director/Board Member | 57 | 07/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/20/01 | Other | Chief Executive Officer | 2,00,000 | 0.0032% | ||
| 31/20/31 | Other | Chief Executive Officer | 1,00,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.85% | -5.57% | -17.19% | -37.83% | 353.26Cr | |
| -1.88% | +10.10% | +56.36% | +159.90% | 1,09700Cr | |
| -1.06% | +7.50% | +68.25% | +55.27% | 62TCr | |
| -0.64% | +7.83% | +36.38% | +87.89% | 45TCr | |
| -1.77% | +6.34% | +29.51% | +24.01% | 33TCr | |
| -0.45% | +5.31% | +41.42% | +26.92% | 29TCr | |
| +0.60% | +3.21% | +32.45% | +41.53% | 29TCr | |
| +0.83% | +2.81% | -28.03% | -42.44% | 21TCr | |
| -0.34% | +3.89% | +29.11% | +62.37% | 19TCr | |
| -1.03% | +0.35% | +13.18% | +62.82% | 16TCr | |
| Average | -0.94% | +5.93% | +26.15% | +44.05% | 36.5TCr | |
| Weighted average by Cap. | -0.96% | +8.71% | +42.09% | +79.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 32TCr 4.14TCr 3.63TCr 3.35TCr 3.13TCr 5.88TCr 3,91400Cr 6.02TCr 40TCr 16TCr 1,93100Cr 16TCr 15TCr 6,70400Cr | 34TCr 4.35TCr 3.81TCr 3.52TCr 3.29TCr 6.18TCr 4,11500Cr 6.33TCr 42TCr 16TCr 2,03000Cr 16TCr 16TCr 7,04800Cr |
| Net income | 482.57Cr 62Cr 54Cr 50Cr 46Cr 87Cr 5.82TCr 89Cr 598.5Cr 231.05Cr 2.87TCr 231.06Cr 225.99Cr 9.96TCr | 522.18Cr 67Cr 58Cr 54Cr 50Cr 95Cr 6.29TCr 97Cr 647.63Cr 250.02Cr 3.11TCr 250.03Cr 244.54Cr 11TCr |
| Net Debt | 5.34TCr 680.25Cr 595.63Cr 549.87Cr 513.48Cr 966.59Cr 64TCr 988.61Cr 6.62TCr 2.55TCr 32TCr 2.55TCr 2.5TCr 1,10200Cr | 4.8TCr 611.49Cr 535.42Cr 494.29Cr 461.57Cr 868.89Cr 58TCr 888.68Cr 5.95TCr 2.3TCr 29TCr 2.3TCr 2.25TCr 99TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | HK$4.240 | -3.85% | 1,35,18,000 |
| 29/26/29 | HK$4.410 | +2.32% | 91,57,000 |
| 26/26/26 | HK$4.310 | -2.71% | 1,13,98,225 |
| 25/26/25 | HK$4.430 | -0.23% | 48,05,191 |
| 24/26/24 | HK$4.440 | -1.11% | 58,00,629 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
